Catalent
CTLT
#1590
Rank
A$16.61 B
Marketcap
$91.53
Share price
1.10%
Change (1 day)
50.46%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$1.94

According to Catalent's latest financial reports the company's current EPS (TTM) is -$1.98. In 2022 the company made an earnings per share (EPS) of $3.48 a decrease over its 2021 EPS that were of $5.02.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.94-155.69%
2022$3.48-30.58%
2021$5.0279.67%
2020$2.79114.12%
2019$1.30-15%
2018$1.5375.44%
2017$0.87-22.97%
2016$1.14-59.56%
2015$2.81282.05%
2014$0.73-378.2%
2013-$0.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.21-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.15-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.16 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$9.80-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA